Literature DB >> 24868327

CYP2E1 immunoglobulin G4 subclass antibodies after desflurane anesthesia.

Chrysanthi Batistaki1, George Michalopoulos1, Paraskevi Matsota1, Tzortzis Nomikos1, Konstantinos Kalimeris1, Maria Riga1, Maria Nakou1, Georgia Kostopanagiotou1.   

Abstract

AIM: To investigate CYP2E1 IgG4 autoantibody levels and liver biochemical markers in adult patients after anesthesia with desflurane.
METHODS: Forty patients who were > 18 years old and undergoing elective surgery under general anesthesia with desflurane were studied. Alpha-glutathione-S-transferase (αGST) and IgG4 antibodies against CYP2E1 were measured preoperatively and 96 h postoperatively, as well as complete blood count, prothrombin time (PT), activated partial thromboplastin time (aPTT), international normalized ratio (INR), aspartate aminotransferase (SGOT), alanine aminotransferase (SGPT), g-glutamyl-transpeptidase (gGT), alkaline phosphatase, total serum proteins, albumin and bilirubin. A separate group of 8 patients who received regional anesthesia was also studied for calibration of the methodology used for CYP2E1 IgG4 and αGST measurements. Student's t-test and the Mann-Whitney U test were used for comparison of the continuous variables, and Fisher's exact test was used for the categorical variables. All tests were two-tailed, with statistical significance set as P < 0.05.
RESULTS: None of the patients developed postoperative liver dysfunction, and all patients were successfully discharged from the hospital. No statistically significant difference was observed regarding liver function tests (SGOT, SGPT, γGT, bilirubin, INR), αGST and CYP2E1 IgG4, before and after exposure to desflurane. After dividing patients into two subgroups based on whether or not they had received general anesthesia in the past, no significant difference in the levels of CYP2E1 IgG4 was observed at baseline or 96 h after desflurane administration (P = 0.099 and P = 0.051, respectively). Alpha-GST baseline levels and levels after the intervention also did not differ significantly between these two subgroups (P > 0.1). The mean αGST differences were statistically elevated in men by 2.15 ng/mL compared to women when adjusted for BMI, duration of anesthesia, number of times anesthesia was administered previously and length of hospital stay. No significant difference was observed between patients who received desflurane and those who received regional anesthesia at any time point.
CONCLUSION: There was no difference in CYP2E1 IgG4 or αGST levels after desflurane exposure; further research is required to investigate their role in desflurane-induced liver injury.

Entities:  

Keywords:  Anesthesia; CYP2E1 IgG4; Desflurane; Drug-induced-liver injury; Hepatotoxicity

Year:  2014        PMID: 24868327      PMCID: PMC4033291          DOI: 10.4254/wjh.v6.i5.340

Source DB:  PubMed          Journal:  World J Hepatol


  24 in total

1.  Hepatic necrosis associated with halothane anesthesia.

Authors:  J LINDENBAUM; E LEIFER
Journal:  N Engl J Med       Date:  1963-03-07       Impact factor: 91.245

Review 2.  Glutathione S-transferase in humans in health and disease.

Authors:  P C Hayes; I A Bouchier; G J Beckett
Journal:  Gut       Date:  1991-07       Impact factor: 23.059

3.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 38-1991. A 33-year-old man with dilatation of the ascending aorta and aortic regurgitation.

Authors: 
Journal:  N Engl J Med       Date:  1991-09-19       Impact factor: 91.245

4.  Autoantibodies associated with volatile anesthetic hepatitis found in the sera of a large cohort of pediatric anesthesiologists.

Authors:  Dolores B Njoku; Robert S Greenberg; Mohammed Bourdi; Craig B Borkowf; Elizabeth M Dake; Jackie L Martin; Lance R Pohl
Journal:  Anesth Analg       Date:  2002-02       Impact factor: 5.108

5.  Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis.

Authors:  M Bourdi; W Chen; R M Peter; J L Martin; J T Buters; S D Nelson; L R Pohl
Journal:  Chem Res Toxicol       Date:  1996 Oct-Nov       Impact factor: 3.739

6.  [Psychosocial conditions and intervention in cancer patients].

Authors:  J Balle; M H Claësson
Journal:  Ugeskr Laeger       Date:  1993-08-23

Review 7.  Recognizing drug-induced liver injury: current problems, possible solutions.

Authors:  William M Lee; John R Senior
Journal:  Toxicol Pathol       Date:  2005       Impact factor: 1.902

8.  Reproducible hepatic dysfunction following separate anesthesia with sevoflurane and desflurane.

Authors:  Peter Chi-Ho Chung; Shyh-Ching Chiou; Jau-Min Lien; Allen H Li; Chung-Hang Wong
Journal:  Chang Gung Med J       Date:  2003-05

9.  Desflurane hepatitis associated with hapten and autoantigen-specific IgG4 antibodies.

Authors:  James S Anderson; Noel R Rose; Jackie L Martin; Edmond I Eger; Dolores B Njoku
Journal:  Anesth Analg       Date:  2007-06       Impact factor: 5.108

10.  Halothane-induced hepatitis: A forgotten issue in developing countries: Halothane-induced hepatitis.

Authors:  Peiman Habibollahi; Nastaran Mahboobi; Sara Esmaeili; Saeid Safari; Ali Dabbagh; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2011-01       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.